64, Avenue de la Roseraie
1205, Genève - Switzerland

+41 223 794 643

info@neurix.ch

BACK TO THE TOP

© 2019 by Neurix SA

EXPLORE THE POWER

OF 3D SCREENING

Technology

Highlights

  • Drug distribution closely mimic the distribution across the several cellular layers - simulating realistic scenarios.

UNLIMIT YOUR RESEARCH 

  • Long tissue life span, allowing chronic exposure scenarios for research.

  • Authentic cytoarchitecture and cell interactions/function

  • Capturing in vivo complexity

  • Medium-to-low throughput

  • Human background

  • Production volume meets industry requirements​

Unlimited source due to pluripotent stem cell origin

TOXICITY IN 3D MINIBRAIN SYSTEMS

Custom model developments

We assess toxicity on neural

3D tissues of different composition

Option 1

Option 2

Option 3

MiniBrains with strictly defined ratio of human neurons and human astocytes resulting from a mixture of cells from individual cell lines . Upon request, we are happy to pursue other cell line developments (e.g. microgila, microvessels, tumors and immune cells) in individual projects.

TOXICITY TESTING IN

100% PURE NEURONAL MINIBRAINS

Viablity assessed via resazurin reduction assay

EXPLORE CUSTOMIZABLE TESTING

FOR ANTI CANCER DRUGS

Glioblastoma Spheroids

Different sizes of tissues and spheroids available.

Anti-cancer drug testing in 3D gliobalstoma spheroids and 3D tumor tissues.

Spheroids and tissue produced out of wild type human glioblastoma cell line.

Various modification of human glioblastoma lines could be generated upon reques. Example: human glioblastoma line expressin mCherry fluorescen protein.